Literature DB >> 15569249

Low nNOS protein in the locus coeruleus in major depression.

B Karolewicz1, K Szebeni, C A Stockmeier, L Konick, J C Overholser, G Jurjus, B L Roth, G A Ordway.   

Abstract

Disruptions of glutamatergic and noradrenergic signaling have been postulated to occur in depressive disorders. Glutamate provides excitatory input to the noradrenergic locus coeruleus (LC). In this study, the location of immunoreactivity against neuronal nitric oxide synthase (nNOS), an intracellular mediator of glutamate receptor activation, was examined in the normal human LC, and potential changes in nNOS immunoreactivity that might occur in major depression were evaluated. Tissue containing LC, and a non-limbic, LC projection area (cerebellum) was obtained from 11 to 12 matched pairs of subjects with major depression and control subjects lacking major psychiatric diagnoses. In the LC region, nNOS immunoreactivity was found in large neuromelanin-containing neurons, small neurons lacking neuromelanin, and glial cells. Levels of nNOS immunoreactivity were significantly lower in the LC (- 44%, p < 0.05), but not in the cerebellum, when comparing depressed with control subjects. nNOS levels were positively correlated with brain pH values in depressed, but not control, subjects in both brain regions. Low levels of nNOS in the LC may reflect altered excitatory input to this nucleus in major depression. However, pH appears to effect preservation of nNOS immunoreactivity in subjects with depression. This factor may contribute, in part, to low levels of nNOS in depression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569249      PMCID: PMC2923201          DOI: 10.1111/j.1471-4159.2004.02792.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  63 in total

1.  Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression.

Authors:  Gregory A Ordway; Jane Schenk; Craig A Stockmeier; Warren May; Violetta Klimek
Journal:  Biol Psychiatry       Date:  2003-02-15       Impact factor: 13.382

2.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

3.  Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients.

Authors:  H-G Bernstein; A Heinemann; D Krell; C Mawrin; H Bielau; P Danos; S Diekmann; G Keilhoff; B Bogerts; B Baumann
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

4.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices.

Authors:  J Garthwaite; G Garthwaite; R M Palmer; S Moncada
Journal:  Eur J Pharmacol       Date:  1989-10-17       Impact factor: 4.432

6.  Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice.

Authors:  Vallo Volke; Gregers Wegener; Michel Bourin; Eero Vasar
Journal:  Behav Brain Res       Date:  2003-03-18       Impact factor: 3.332

7.  Different populations of tyrosine-hydroxylase-immunoreactive neurons defined by differential expression of nitric oxide synthase in the human temporal cortex.

Authors:  Ruth Benavides-Piccione; Javier DeFelipe
Journal:  Cereb Cortex       Date:  2003-03       Impact factor: 5.357

8.  Increased serum glutamate in depressed patients.

Authors:  J S Kim; W Schmid-Burgk; D Claus; H H Kornhuber
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

9.  Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain.

Authors:  Hiroaki Tomita; Marquis P Vawter; David M Walsh; Simon J Evans; Prabhakara V Choudary; Jun Li; Kevin M Overman; Mary E Atz; Richard M Myers; Edward G Jones; Stanley J Watson; Huda Akil; William E Bunney
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

10.  The influence of agonal status on some neurochemical activities of postmortem human brain tissue.

Authors:  E K Perry; R H Perry; B E Tomlinson
Journal:  Neurosci Lett       Date:  1982-04-26       Impact factor: 3.046

View more
  17 in total

1.  Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovács; Myra G Nunez; Alice A Larson
Journal:  Pharmacol Res       Date:  2013-11-04       Impact factor: 7.658

2.  Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes.

Authors:  Rafael T de Sousa; Marcus V Zanetti; Geraldo F Busatto; Margaret G Mouro; Carlos A Zarate; Wagner F Gattaz; Elisa M Higa; Rodrigo Machado-Vieira
Journal:  J Psychiatr Res       Date:  2014-04-12       Impact factor: 4.791

3.  Association between polymorphisms of NOS1, NOS2 and NOS3 genes and suicide behavior: a systematic review and meta-analysis.

Authors:  Thelma Beatriz González-Castro; Alma Delia Genis-Mendoza; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; María Lilia López-Narvaez; Nonanzit Pérez-Hernández; José Manuel Rodríguez-Pérez; José Jaime Martínez-Magaña
Journal:  Metab Brain Dis       Date:  2019-03-21       Impact factor: 3.584

4.  GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.

Authors:  Grazyna Rajkowska; Gillian O'Dwyer; Zsofia Teleki; Craig A Stockmeier; Jose Javier Miguel-Hidalgo
Journal:  Neuropsychopharmacology       Date:  2006-10-25       Impact factor: 7.853

5.  Endothelial nitric oxide synthase in rat brain is downregulated by sub-chronic antidepressant treatment.

Authors:  Yuta Yoshino; Shinichiro Ochi; Kiyohiro Yamazaki; Shunsuke Nakata; Jun-Ichi Iga; Shu-Ichi Ueno
Journal:  Psychopharmacology (Berl)       Date:  2017-03-08       Impact factor: 4.530

6.  Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression.

Authors:  Beata Karolewicz; Craig A Stockmeier; Gregory A Ordway
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

7.  Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.

Authors:  R Bernard; I A Kerman; R C Thompson; E G Jones; W E Bunney; J D Barchas; A F Schatzberg; R M Myers; H Akil; S J Watson
Journal:  Mol Psychiatry       Date:  2010-04-13       Impact factor: 15.992

8.  Glutamate signaling proteins and tyrosine hydroxylase in the locus coeruleus of alcoholics.

Authors:  Beata Karolewicz; Laurel Johnson; Katalin Szebeni; Craig A Stockmeier; Gregory A Ordway
Journal:  J Psychiatr Res       Date:  2007-05-03       Impact factor: 4.791

9.  Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity.

Authors:  B Chanrion; C Mannoury la Cour; F Bertaso; M Lerner-Natoli; M Freissmuth; M J Millan; J Bockaert; P Marin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

10.  Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression.

Authors:  Beata Karolewicz; Katalin Szebeni; Tempestt Gilmore; Dorota Maciag; Craig A Stockmeier; Gregory A Ordway
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.